16 Sep S-Ventures PLC – first day of dealing
16 September 2020
RNS Number : 0808Z
S-Ventures PLC
16 September 2020
16 September 2020
S-VENTURES PLC
( “S-Ventures” or the “Company” )
Admission to the AQSE Growth Market
S-Ventures Plc, an Investment Vehicle established for the purpose of identifying investment opportunities in the Wellness, Wellbeing, and Organic Foods sectors in the UK and Europe is pleased to announce that trading in its Ordinary Shares will commence at 8:00 a.m. today on the AQSE Growth Market (“Admission”), under the ticker SVEN and ISIN number GB00BN29LY68.
Company Information
The Company has raised GBP650,400 before expenses though the issue of 24,390,000 Ordinary Shares to identify investment opportunities in the wellness sector within the UK and Europe. The Company plans to add value by applying capital and expertise to the business operations and strategic plans of investee companies. The experience and operational skills of the Board are intended to act as an accelerator to small brands that have an established but sub-scale market presence, strong foundations and platforms but lack skills and capital to maximise their profit opportunity.
Directors Shareholdings
On Admission the interests of the Directors and their immediate families and, so far as they are aware having made due and careful enquiries, of persons connected with them (all of which are beneficial, unless otherwise stated) (so far as is known to the Directors, or could with reasonable diligence be ascertained by them) (within the meaning of sections 252 to 254 of the UK Companies Act 2006) in the Issued Share Capital are as follows:
Director Number of Ordinary Shares on % of Issued Admission Share Capital Scott Livingston* 46,500,000 62.5 Robert Hewitt 2,187,500 2.9 Nick D’Onofrio 2,750,000 3.7 Alexander Phillips 2,750,000 3.7
* this includes the holdings of: Louisa Jane Bohan, a relative of Scott Livingston, who holds 2,375,000 shares; Filomena Livingston, a relative of Scott Livingston who holds 500,000 shares), and Iain Livingston, a relative of Scott Livingston, who holds 562,500 shares
Notifiable Interests
In addition to the Directors holdings disclosed above, the Company has been notified or is aware of the following holdings which will, following Admission, represent more than 3 per cent. of the Issued Share Capital or voting rights of the Company:
Name Number of Ordinary Shares % of Issued on Admission Share Capital Ayesha Mary Barbara Vardag 3,750,000 5.0 Silver Star Holdings Ltd 3,750,000 5.0 Sherwood International Holdings Ltd 3,750,000 5.0 Louisa Jane Bohan 2,375,000 3.2
Total Voting Rights
Following the issue of the 24,390,000 Subscription Shares, the Company has 74,390,000 Ordinary Shares of 0.1p in issue, which also represents the total number of voting rights in the Company. This figure should be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA’s Disclosure and Transparency Rules.
The definitions used in this announcement have the same meaning as they have in the Admission Document.
Scott Livingston, Director, said:
“We are delighted to list on AQUIS at an important time for the exchange and its new team, we are excited to be part of its growth story. We are looking forward to creating value for our investors and other stakeholders, capitalising on the plethora of investment opportunities that we anticipate will arise in the consumer wellbeing sector. And we are delighted to have received investments at the time of our admission from a number of prominent businesspeople who form a very strong cohort of supporters for our long-term plans. Among these investors are the chairman of McLaren and former CEO of Diageo, Paul Walsh; Fortress investment group billionaire and former Goldman Sachs partner, Pete Briger; renowned lawyer, Ayesha Vardag; and super yacht entrepreneur, Charlie Birkett.”
The Directors of the Company accept responsibility for the contents of this announcement.
For further information, please contact:
The Company Robert Hewitt +44 (0) 1932 400 224 AQSE Corporate Adviser: Peterhouse Capital Limited Guy Miller/Allie Feuerlein +44 (0) 20 7469 0936
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.